Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry

• Laurent Fauchier ,

  * E-mail: lfau@med.univ-tours.fr

  Affiliation Service de Cardiologie, Centre Hospitalier Universitaire Trousseau and Université François Rabelais, Tours, France

  ⨯
• Nicola Greenlaw,

  Affiliation Robertson Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Roberto Ferrari,

  Affiliation Department of Cardiology, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care&Research, E.S. Health Science Foundation, Cotignola, Italy

  ⨯
• Ian Ford,

  Affiliation Robertson Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Kim M. Fox,

  Affiliation NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom

  ⨯
• Jean-Claude Tardif,

  Affiliation Montreal Heart Institute, Université de Montreal, Montreal, Canada

  ⨯
• Michal Tendera,

  Affiliation Medical University of Silesia, Katowice, Poland

  ⨯
• Ph. Gabriel Steg,

  Affiliations NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom, Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France, INSERM U-1148, Paris, France, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Assistance Publique—Hôpitaux de Paris, Paris, France

  ⨯
• CLARIFY Investigators

  ¶Membership of the CLARIFY Investigators is provided in the Acknowledgments.

  ⨯